1. Home
  2. ANDE vs URGN Comparison

ANDE vs URGN Comparison

Compare ANDE & URGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Andersons Inc. (The)

ANDE

Andersons Inc. (The)

HOLD

Current Price

$65.54

Market Cap

2.4B

Sector

Industrials

ML Signal

HOLD

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

HOLD

Current Price

$47.44

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANDE
URGN
Founded
1947
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2005
2016

Fundamental Metrics

Financial Performance
Metric
ANDE
URGN
Price
$65.54
$47.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$75.00
$29.29
AVG Volume (30 Days)
294.2K
808.9K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
1.03%
N/A
EPS Growth
N/A
N/A
EPS
2.62
N/A
Revenue
$11,008,928,000.00
$1,128,000.00
Revenue This Year
$7.28
$129.09
Revenue Next Year
$3.57
$70.96
P/E Ratio
$25.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.63
$15.86
52 Week High
$82.11
$48.03

Technical Indicators

Market Signals
Indicator
ANDE
URGN
Relative Strength Index (RSI) 40.51 67.02
Support Level $64.75 $18.23
Resistance Level $73.40 N/A
Average True Range (ATR) 3.32 2.41
MACD -0.87 0.07
Stochastic Oscillator 1.53 78.59

Price Performance

Historical Comparison
ANDE
URGN

About ANDE Andersons Inc. (The)

Andersons Inc is an agriculture and renewable fuels company. Its operations are classified into two reportable business segments: Agribusiness, which generates maximum revenue, and Renewables. The Agribusiness segment includes merchandising and managing logistics across various commodities, as well as being a manufacturer, distributor, and retailer of agricultural and related plant nutrients. The segment specializes in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. The Renewables segment mainly produces, purchases, and sells ethanol and co-products. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

Share on Social Networks: